Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 109

1.

Variant Ciz1 is a circulating biomarker for early-stage lung cancer.

Higgins G, Roper KM, Watson IJ, Blackhall FH, Rom WN, Pass HI, Ainscough JF, Coverley D.

Proc Natl Acad Sci U S A. 2012 Nov 6;109(45):E3128-35. doi: 10.1073/pnas.1210107109. Epub 2012 Oct 16.

PMID:
23074256
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Cyfra 21-1 as a biologic marker of non-small cell lung cancer. Evaluation of sensitivity, specificity, and prognostic role.

Wieskopf B, Demangeat C, Purohit A, Stenger R, Gries P, Kreisman H, Quoix E.

Chest. 1995 Jul;108(1):163-9.

PMID:
7541742
[PubMed - indexed for MEDLINE]
3.

Serum proteomic profiling of lung cancer in high-risk groups and determination of clinical outcomes.

Jacot W, Lhermitte L, Dossat N, Pujol JL, Molinari N, Daurès JP, Maudelonde T, Mangé A, Solassol J.

J Thorac Oncol. 2008 Aug;3(8):840-50. doi: 10.1097/JTO.0b013e31817e464a.

PMID:
18670301
[PubMed - indexed for MEDLINE]
4.

Panel of serum biomarkers for the diagnosis of lung cancer.

Patz EF Jr, Campa MJ, Gottlin EB, Kusmartseva I, Guan XR, Herndon JE 2nd.

J Clin Oncol. 2007 Dec 10;25(35):5578-83.

PMID:
18065730
[PubMed - indexed for MEDLINE]
5.

Circulating miR-125b is a novel biomarker for screening non-small-cell lung cancer and predicts poor prognosis.

Yuxia M, Zhennan T, Wei Z.

J Cancer Res Clin Oncol. 2012 Dec;138(12):2045-50. doi: 10.1007/s00432-012-1285-0. Epub 2012 Jul 18.

PMID:
22806310
[PubMed - indexed for MEDLINE]
6.

[Clinical usefulness of a new tumor marker CYFRA21-1 in patients with lung cancer].

Li R, Li R, Wang Y.

Zhonghua Jie He He Hu Xi Za Zhi. 1998 Jan;21(1):26-9. Chinese.

PMID:
11263296
[PubMed - indexed for MEDLINE]
7.

Circulating plasma DNA as diagnostic biomarker in non-small cell lung cancer.

Paci M, Maramotti S, Bellesia E, Formisano D, Albertazzi L, Ricchetti T, Ferrari G, Annessi V, Lasagni D, Carbonelli C, De Franco S, Brini M, Sgarbi G, Lodi R.

Lung Cancer. 2009 Apr;64(1):92-7. doi: 10.1016/j.lungcan.2008.07.012. Epub 2008 Sep 19.

PMID:
18804892
[PubMed - indexed for MEDLINE]
8.

Plasma proGRP concentration is sensitive and specific for discriminating small cell lung cancer from nonmalignant conditions or non-small cell lung cancer.

Kim HR, Oh IJ, Shin MG, Park JS, Choi HJ, Ban HJ, Kim KS, Kim YC, Shin JH, Ryang DW, Suh SP.

J Korean Med Sci. 2011 May;26(5):625-30. doi: 10.3346/jkms.2011.26.5.625. Epub 2011 Apr 21.

PMID:
21532852
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Low levels of cell-free circulating miR-361-3p and miR-625* as blood-based markers for discriminating malignant from benign lung tumors.

Roth C, Stückrath I, Pantel K, Izbicki JR, Tachezy M, Schwarzenbach H.

PLoS One. 2012;7(6):e38248. doi: 10.1371/journal.pone.0038248. Epub 2012 Jun 4.

PMID:
22675530
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Cancer-associated variant expression and interaction of CIZ1 with cyclin A1 in differentiating male germ cells.

Greaves EA, Copeland NA, Coverley D, Ainscough JF.

J Cell Sci. 2012 May 15;125(Pt 10):2466-77. doi: 10.1242/jcs.101097. Epub 2012 Feb 24.

PMID:
22366453
[PubMed - indexed for MEDLINE]
Free Article
11.

Methylation markers of early-stage non-small cell lung cancer.

Lokk K, Vooder T, Kolde R, Välk K, Võsa U, Roosipuu R, Milani L, Fischer K, Koltsina M, Urgard E, Annilo T, Metspalu A, Tõnisson N.

PLoS One. 2012;7(6):e39813. doi: 10.1371/journal.pone.0039813. Epub 2012 Jun 29.

PMID:
22768131
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Usefulness of serum tumor markers, including progastrin-releasing peptide, in patients with lung cancer: correlation with histology.

Molina R, Augé JM, Bosch X, Escudero JM, Viñolas N, Marrades R, Ramírez J, Carcereny E, Filella X.

Tumour Biol. 2009;30(3):121-9. doi: 10.1159/000224628. Epub 2009 Jun 9.

PMID:
19506400
[PubMed - indexed for MEDLINE]
13.

Serum Sialyl Lewis x and cytokeratin 19 fragment as predictive factors for recurrence in patients with stage I non-small cell lung cancer.

Mizuguchi S, Nishiyama N, Iwata T, Nishida T, Izumi N, Tsukioka T, Inoue K, Uenishi T, Wakasa K, Suehiro S.

Lung Cancer. 2007 Dec;58(3):369-75. Epub 2007 Aug 13.

PMID:
17697728
[PubMed - indexed for MEDLINE]
14.

Cell cycle protein cyclin Y is associated with human non-small-cell lung cancer proliferation and tumorigenesis.

Yue W, Zhao X, Zhang L, Xu S, Liu Z, Ma L, Jia W, Qian Z, Zhang C, Wang Y, Yang X.

Clin Lung Cancer. 2011 Jan;12(1):43-50. doi: 10.3816/CLC.2011.n.006.

PMID:
21273179
[PubMed - indexed for MEDLINE]
15.

Plasma microRNAs as potential biomarkers for non-small-cell lung cancer.

Shen J, Todd NW, Zhang H, Yu L, Lingxiao X, Mei Y, Guarnera M, Liao J, Chou A, Lu CL, Jiang Z, Fang H, Katz RL, Jiang F.

Lab Invest. 2011 Apr;91(4):579-87. doi: 10.1038/labinvest.2010.194. Epub 2010 Nov 29.

PMID:
21116241
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Epithelial-specific methylation marker: a potential plasma biomarker in advanced non-small cell lung cancer.

Vinayanuwattikun C, Sriuranpong V, Tanasanvimon S, Chantranuwat P, Mutirangura A.

J Thorac Oncol. 2011 Nov;6(11):1818-25. doi: 10.1097/JTO.0b013e318226b46f.

PMID:
21964525
[PubMed - indexed for MEDLINE]
17.

The diagnostic and prognostic value of ProGRP in lung cancer.

Nisman B, Biran H, Ramu N, Heching N, Barak V, Peretz T.

Anticancer Res. 2009 Nov;29(11):4827-32.

PMID:
20032442
[PubMed - indexed for MEDLINE]
Free Article
19.

Circulating serum vascular endothelial growth factor is not a prognostic factor of non-small cell lung cancer.

Chakra M, Pujol JL, Lamy PJ, Bozonnat MC, Quantin X, Jacot W, Daurès JP.

J Thorac Oncol. 2008 Oct;3(10):1119-26. doi: 10.1097/JTO.0b013e318187464e.

PMID:
18827607
[PubMed - indexed for MEDLINE]
20.

Development of a membrane array-based multimarker assay for detection of circulating cancer cells in patients with non-small cell lung cancer.

Sheu CC, Yu YP, Tsai JR, Chang MY, Lin SR, Hwang JJ, Chong IW.

Int J Cancer. 2006 Sep 15;119(6):1419-26.

PMID:
16642481
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk